scholarly journals Cover Picture: Luminescent Rhenium(I) Polypyridine Complexes Appended with an α-D-Glucose Moiety as Novel Biomolecular and Cellular Probes (Chem. Eur. J. 30/2011)

2011 ◽  
Vol 17 (30) ◽  
pp. 8229-8229
Author(s):  
Man-Wai Louie ◽  
Hua-Wei Liu ◽  
Marco Ho-Chuen Lam ◽  
Yun-Wah Lam ◽  
Kenneth Kam-Wing Lo
ChemInform ◽  
2011 ◽  
Vol 42 (41) ◽  
pp. no-no
Author(s):  
Kenneth Kam-Wing Lo ◽  
Kenneth Yin Zhang ◽  
Steve Po-Yam Li

2011 ◽  
Vol 17 (30) ◽  
pp. 8304-8308 ◽  
Author(s):  
Man-Wai Louie ◽  
Hua-Wei Liu ◽  
Marco Ho-Chuen Lam ◽  
Yun-Wah Lam ◽  
Kenneth Kam-Wing Lo

2011 ◽  
Vol 83 (4) ◽  
pp. 823-840 ◽  
Author(s):  
Kenneth Kam-Wing Lo ◽  
Kenneth Yin Zhang ◽  
Steve Po-Yam Li

The interesting emission properties of cyclometalated iridium(III) polypyridine complexes, originated from a range of excited states, have been well documented. The intense and long-lived emission of these complexes has been exploited in various areas of research including photovoltaic cells, chemosensors, and light-emitting devices. Additionally, there is an emerging interest in the applications of these luminescent complexes in various biological studies. In this paper, we summarize our recent work on the utilization of luminescent cyclometalated iridium(III) polypyridine complexes as biomolecular and cellular probes.


2020 ◽  
Author(s):  
Johannes Karges ◽  
Shi Kuang ◽  
Federica Maschietto ◽  
Olivier Blacque ◽  
Ilaria Ciofini ◽  
...  

<div>The use of photodynamic therapy (PDT) against cancer has received increasing attention overthe recent years. However, the application of the currently approved photosensitizers (PSs) is somehow limited by their poor aqueous solubility, aggregation, photobleaching and slow clearance from the body. To overcome these limitations, there is a need for the development of new classes of PSs with ruthenium(II) polypyridine complexes currently gaining momentum. However, these compounds generally lack significant absorption in the biological spectral window, limiting their application to treat deep-seated or large tumors. To overcome this drawback, ruthenium(II) polypyridine complexes designed in silico with (E,E’)-4,4´-bisstyryl 2,2´-bipyridine ligands showed impressive 1- and 2-Photon absorption up to a magnitude higher than the ones published so far. While non-toxic in the dark, these compounds were found phototoxic in various 2D monolayer cells, 3D multicellular tumor spheroids and be able to eradicate a multiresistant tumor inside a mouse model upon clinically relevant 1-Photon and 2 Photon excitation.</div>


1986 ◽  
Vol 60 (1) ◽  
pp. 230-241 ◽  
Author(s):  
H T Cuypers ◽  
G C Selten ◽  
M Zijlstra ◽  
R E de Goede ◽  
C J Melief ◽  
...  

1999 ◽  
Vol 38 (10) ◽  
pp. 2267-2278 ◽  
Author(s):  
Joseph A. Treadway ◽  
Thomas J. Meyer

Author(s):  
Guang-Xi Xu ◽  
Eunice Chiu-Lam Mak ◽  
Kenneth Kam-Wing Lo

By virtue of their rich photophysical and photochemical properties, transition metal complexes (TMCs) have been extensively studied in multidisciplinary research. In this review, recent studies on TMCs for biological applications...


Sign in / Sign up

Export Citation Format

Share Document